Steroid-Free Immunosuppression in Kidney Transplant Recipients and Prograf Monotherapy: An Interim Analysis of a Prospective Multicenter Trial

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2654-2656

  Backman L ^a   Aselius H ^a   Lindberger, K ^a   Svensson, L ^a   Strombom U ^a   Olausson, E ^a   Hadimeri, H ^a   Deurell, S I ^a   Norrby, J ^a   Gabel M ^a   Ebermark, A ^a   Olausson, M ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TSUKUBAENOLIDE;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DEPRESSION; DIABETES MELLITUS; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; CREATININE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750624165     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.07.026     Document Type: Article

References (7)

1. Artz M.A., Boots J.M., Lightenberg G., et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function, and cardiovascular risk profile. Am J Transplantation 4 (2004) 937
2. Brazier J., Harper R., Jones M., et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305 (1992) 160
3. United Network for Organ Sharing (UNOS) Database 1987-1999
4. United States Renal Data System (USRDS) Database 1994-2000
5. Jurewicz A. Tacrolimus versus ciclosporin immunosuppression: long term outcome in renal transplantation. Nephrol Dial Transplant 18 (2003) 7
6. Lightenberg G., Hene R.J., Blankenstijn P.J., et al. Cardiovascular risk factors in renal transolant patients: cyclosporine A versus tacrolimus. J Am Soc Nephrol 12 (2001) 368
7. Margreiter R., Pohanka E., Sparacino V., et al. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related-side-effects. Transplant Int 18 (2005) 816